Tilman Schöning

Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial

Karsten Geletneky, Jacek Hajda, Assia L. Angelova et al. · Molecular Therapy · 2017 · 249 citations · Full text

A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol

Jacek Hajda, Monika Lehmann, Ottheinz Krebs et al. · BMC Cancer · 2017 · 44 citations · Full text

Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data

Patrick Derigs, Aleksandar Radujkovic, Maria‐Luisa Schubert et al. · Annals of Hematology · 2020 · 40 citations · Full text

Antitumor Effects of Proteasome Inhibition in Anaplastic Thyroid Carcinoma

Annette Altmann, Annette Markert, Vasileios Askoxylakis et al. · Journal of Nuclear Medicine · 2012 · 36 citations · Full text

Nonpegylated Liposomal Doxorubicin as a Component of R-CHOP Is an Effective and Safe Alternative to Conventional Doxorubicin in the Treatment of Patients With Diffuse Large B-Cell Lymphoma and Preexisting Cardiac Diseases

Sarah Rohlfing, Matthias Aurich, Tilman Schöning et al. · Clinical Lymphoma Myeloma & Leukemia · 2015 · 19 citations

Lymphoid Neoplasia, Oncology, Medicine +12